{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:54:03Z","timestamp":1790916843467,"version":"4.1.0"},"reference-count":187,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is a female endocrine and reproductive disease.\nThe exact etiology remains unknown. There are several associated factors involved in the pathogenesis\nof PCOS, such as hyperandrogenism, insulin resistance, obesity, inflammation, oxidative\nstress, genetic, epigenetic, and environmental factors. However, the main diagnostic criteria\ninvolve at least two out of three symptoms, which are hyperandrogenism, polycystic ovaries,\nand menstrual cycle dysregulation. The treatment of the multiple symptoms of PCOS is still a\nmedical challenge. Different molecular pathways have been studied in PCOS, such as PI3KAKT,\nMAPK, NF-\u03baB, and Keap-1-Nrf2 pathways, to visualize different mechanisms of action\nof this disease. In this regard, this review highlights the main signaling pathways involved in\nPCOS, as well as their associated studies retrieved from PubMed and Web of Science databases.\nIn addition, several therapeutic approaches and targets that were tested on letrozole-induced\nPCOS in rodents were summarized and retrieved from the same databases over the past five\nyears. For example, resveratrol, patuletin, adropin, mogroside V, Lepidium sativum seed extract,\nascorbic acid, alendronate, probiotics, and mesenchymal stem cells, as well as lifestyle modifications,\nwere shown to have positive effects in the management of PCOS. In conclusion, different\napproaches have been studied as potential treatments for PCOS according to different disease\npathogeneses, molecular pathways, and associated symptoms, showing promising results\nthat might be included in the PCOS therapeutic plan in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010433981251031050335","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:18:41Z","timestamp":1772176721000},"page":"1075-1097","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Polycystic Ovarian Syndrome (PCOS): A Brief Overview on Pathogenesis, Main Signaling Pathways, and Recent Studies Performed on Letrozole-induced PCOS in Rodents"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0828-1793","authenticated-orcid":true,"given":"Hana N.","family":"Abduljabbar","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9253-7620","authenticated-orcid":true,"given":"Maha H.","family":"Jamal","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-9300","authenticated-orcid":true,"given":"Ahmed","family":"Esmat","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia"},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"Bozdag G.","year":"2016","unstructured":"Bozdag G.; Mumusoglu S.; Zengin D.; Karabulut E.; Yildiz B.O.; The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod  2016,31(12),2841-2855","journal-title":"Hum Reprod"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"Escobar-Morreale H.F.","year":"2018","unstructured":"Escobar-Morreale H.F.; Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol  2018,14(5),270-284","journal-title":"Nat Rev Endocrinol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","volume":"23","author":"Sadeghi H.M.","year":"2022","unstructured":"Sadeghi H.M.; Adeli I.; Calina D.; Docea A.O.; Mousavi T.; Daniali M.; Nikfar S.; Tsatsakis A.; Abdollahi M.; Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci  2022,23(2),583","journal-title":"Int J Mol Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"bnaa010","DOI":"10.1210\/endrev\/bnaa010","volume":"41","author":"Stener-Victorin E.","year":"2020","unstructured":"Stener-Victorin E.; Padmanabhan V.; Walters K.A.; Campbell R.E.; Benrick A.; Giacobini P.; Dumesic D.A.; Abbott D.H.; Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev  2020,41(4),bnaa010","journal-title":"Endocr Rev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"Teede H.J.","year":"2023","unstructured":"Teede H.J.; Tay C.T.; Laven J.J.E.; Dokras A.; Moran L.J.; Piltonen T.T.; Costello M.F.; Boivin J.; Redman L.M.; Boyle J.A.; Norman R.J.; Mousa A.; Joham A.E.; Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab  2023,108(10),2447-2469","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/biolre\/ioz117","volume":"101","author":"Tetkova A.","year":"2019","unstructured":"Tetkova A.; Susor A.; Kubelka M.; Nemcova L.; Jansova D.; Dvoran M.; Del Llano E.; Holubcova Z.; Kalous J.; Follicle-stimulating hormone administration affects amino acid metabolism in mammalian oocytes. Biol Reprod  2019,101(4),719-732","journal-title":"Biol Reprod"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/dna.2018.4467","volume":"38","author":"O\u017cegowska K.","year":"2019","unstructured":"O\u017cegowska K.; Br\u0105zert M.; Ciesi\u00f3\u0142ka S.; Nawrocki M.J.; Kranc W.; Celichowski P.; Jankowski M.; Bryja A.; Jeseta M.; Antosik P.; Bukowska D.; Skowro\u0144ski M.T.; Bruska M.; Pawelczyk L.; Zabel M.; Nowicki M.; Kempisty B.; Genes involved in the processes of cell proliferation, migration, adhesion, and tissue development as new potential markers of porcine granulosa cellular processes in vitro : A microarray approach. DNA Cell Biol  2019,38(6),549-560","journal-title":"DNA Cell Biol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13287-021-02529-w","volume":"12","author":"Shareghi-oskoue O.","year":"2021","unstructured":"Shareghi-oskoue O.; Aghebati-Maleki L.; Yousefi M.; Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure. Stem Cell Res Ther  2021,12(1),454","journal-title":"Stem Cell Res Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-44558-8_1","author":"Davis H.C.","year":"2017","unstructured":"Davis H.C.; Hackney A.C.; The hypothalamic-pituitary-ovarian axis and oral contraceptives: Regulation and function. Sex Hormones, Exercise and Women  2017,1-10","journal-title":"Sex Hormones, Exercise and Women"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1210\/jc.2019-00780","volume":"104","author":"Owens L.A.","year":"2019","unstructured":"Owens L.A.; Kristensen S.G.; Lerner A.; Christopoulos G.; Lavery S.; Hanyaloglu A.C.; Hardy K.; Yding Andersen C.; Franks S.; Gene expression in granulosa cells from small antral follicles from women with or without polycystic ovaries. J Clin Endocrinol Metab  2019,104(12),6182-6192","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.beem.2022.101665","volume":"36","author":"Naamneh Elzenaty R.","year":"2022","unstructured":"Naamneh Elzenaty R.; du Toit T.; Fl\u00fcck C.E.; Basics of androgen synthesis and action. Best Pract Res Clin Endocrinol Metab  2022,36(4),101665","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"100085","DOI":"10.1016\/j.endmts.2021.100085","volume":"3","author":"Bulsara J.","year":"2021","unstructured":"Bulsara J.; Patel P.; Soni A.; Acharya S.; A review: Brief insight into polycystic ovarian syndrome. Endocr Metab Sci  2021,3,100085","journal-title":"Endocr Metab Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0954422418000136","volume":"31","author":"Barrea L.","year":"2018","unstructured":"Barrea L.; Marzullo P.; Muscogiuri G.; Di Somma C.; Scacchi M.; Orio F.; Aimaretti G.; Colao A.; Savastano S.; Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev  2018,31(2),291-301","journal-title":"Nutr Res Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bone.2015.04.015","volume":"80","author":"Carson J.A.","year":"2015","unstructured":"Carson J.A.; Manolagas S.C.; Effects of sex steroids on bones and muscles: Similarities, parallels, and putative interactions in health and disease. Bone  2015,80,67-78","journal-title":"Bone"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43042-019-0031-4","volume":"25","author":"Ashraf S.","unstructured":"Ashraf S.; Nabi M.; Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: A review. Egypt J Med Hum Genet  ,25,20","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s12015-023-10505-5","volume":"19","author":"Karam M.","year":"2023","unstructured":"Karam M.; Najjar H.; El Sabban M.; Hamade A.; Najjar F.; Regenerative medicine for polycystic ovary syndrome: Stem cell-based therapies and brown adipose tissue activation. Stem Cell Rev Rep  2023,19(4),853-865","journal-title":"Stem Cell Rev Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/jcmm.16205","volume":"25","author":"Ye W.","year":"2021","unstructured":"Ye W.; Xie T.; Song Y.; Zhou L.; The role of androgen and its related signals in PCOS. J Cell Mol Med  2021,25(4),1825-1837","journal-title":"J Cell Mol Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1273542","DOI":"10.3389\/fendo.2023.1273542","volume":"14","author":"Wang K.","year":"2023","unstructured":"Wang K.; Li Y.; Chen Y.; Androgen excess: A hallmark of polycystic ovary syndrome. Front Endocrinol  2023,14,1273542","journal-title":"Front Endocrinol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"667422","DOI":"10.3389\/fendo.2021.667422","volume":"12","author":"Liao B.","year":"2021","unstructured":"Liao B.; Qiao J.; Pang Y.; Central regulation of PCOS: Abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology. Front Endocrinol  2021,12,667422","journal-title":"Front Endocrinol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"Armanini D.","year":"2022","unstructured":"Armanini D.; Boscaro M.; Bordin L.; Sabbadin C.; Controversies in the pathogenesis, diagnosis and treatment of PCOS: Focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci  2022,23(8),4110","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1172\/JCI114745","volume":"86","author":"Cara J.F.","year":"1990","unstructured":"Cara J.F.; Fan J.; Azzarello J.; Rosenfield R.L.; Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J Clin Invest  1990,86(2),560-565","journal-title":"J Clin Invest"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"154458","DOI":"10.1016\/j.metabol.2020.154458","volume":"115","author":"Chahal N.","year":"2021","unstructured":"Chahal N.; Geethadevi A.; Kaur S.; Lakra R.; Nagendra A.; Shrivastav T.G.; De Pascali F.; Reiter E.; Cr\u00e9pieux P.; Devi M.G.; Malhotra N.; Muralidhar K.; Singh R.; Direct impact of gonadotropins on glucose uptake and storage in preovulatory granulosa cells: Implications in the pathogenesis of polycystic ovary syndrome. Metabolism  2021,115,154458","journal-title":"Metabolism"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s13679-023-00531-2","volume":"13","author":"Lonardo M.S.","year":"2024","unstructured":"Lonardo M.S.; Cacciapuoti N.; Guida B.; Di Lorenzo M.; Chiurazzi M.; Damiano S.; Menale C.; Hypothalamic-ovarian axis and adiposity relationship in polycystic ovary syndrome: Physiopathology and therapeutic options for the management of metabolic and inflammatory aspects. Curr Obes Rep  2024,13(1),51-70","journal-title":"Curr Obes Rep"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"Zeng X.","year":"2020","unstructured":"Zeng X.; Xie Y.; Liu Y.; Long S.; Mo Z.; Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta  2020,502,214-221","journal-title":"Clin Chim Acta"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41598-020-57672-w","volume":"10","author":"Salehi R.","year":"2020","unstructured":"Salehi R.; Mazier H.L.; Nivet A.L.; Reunov A.A.; Lima P.; Wang Q.; Fiocco A.; Isidoro C.; Tsang B.K.; Ovarian mitochondrial dynamics and cell fate regulation in an androgen-induced rat model of polycystic ovarian syndrome. Sci Rep  2020,10(1),1021","journal-title":"Sci Rep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1210\/en.2019-00588","volume":"160","author":"Fox C.W.","year":"2019","unstructured":"Fox C.W.; Zhang L.; Sohni A.; Doblado M.; Wilkinson M.F.; Chang R.J.; Duleba A.J.; Inflammatory stimuli trigger increased androgen production and shifts in gene expression in theca-interstitial cells. Endocrinology  2019,160(12),2946-2958","journal-title":"Endocrinology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567","volume":"35","author":"Li X.","year":"2019","unstructured":"Li X.; Qi J.; Zhu Q.; He Y.; Wang Y.; Lu Y.; Wu H.; Sun Y.; The role of androgen in autophagy of granulosa cells from PCOS. Gynecol Endocrinol  2019,35(8),669-672","journal-title":"Gynecol Endocrinol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/09513590.2019.1653844","volume":"36","author":"Qiu X.","year":"2020","unstructured":"Qiu X.; Wei Y.; Liu C.; Ding C.; Zhao S.; Hyperandrogen enhances apoptosis of human ovarian granulosa cells via up-regulation and demethylation of PDCD4. Gynecol Endocrinol  2020,36(4),333-337","journal-title":"Gynecol Endocrinol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","volume":"18","author":"Zhao H.","year":"2021","unstructured":"Zhao H.; Xing C.; Zhang J.; He B.; Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: A network meta-analysis. Reprod Health  2021,18(1),171","journal-title":"Reprod Health"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"Zhao H.","year":"2023","unstructured":"Zhao H.; Zhang J.; Cheng X.; Nie X.; He B.; Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment. J Ovarian Res  2023,16(1),9","journal-title":"J Ovarian Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/metabo11120869","volume":"11","author":"Chen W.","year":"2021","unstructured":"Chen W.; Pang Y.; Metabolic syndrome and PCOS: Pathogenesis and the role of metabolites. Metabolites  2021,11(12),869","journal-title":"Metabolites"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.repbio.2015.12.006","volume":"16","author":"Cadagan D.","year":"2016","unstructured":"Cadagan D.; Khan R.; Amer S.; Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome. Reprod Biol  2016,16(1),53-60","journal-title":"Reprod Biol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/humrep\/deh609","volume":"20","author":"Rice S.","year":"2005","unstructured":"Rice S.; Christoforidis N.; Gadd C.; Nikolaou D.; Seyani L.; Donaldson A.; Margara R.; Hardy K.; Franks S.; Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod  2005,20(2),373-381","journal-title":"Hum Reprod"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"741764","DOI":"10.3389\/fendo.2021.741764","volume":"12","author":"Ding H.","year":"2021","unstructured":"Ding H.; Zhang J.; Zhang F.; Zhang S.; Chen X.; Liang W.; Xie Q.; Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Front Endocrinol  2021,12,741764","journal-title":"Front Endocrinol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/db13-1514","volume":"63","author":"Wu S.","year":"2014","unstructured":"Wu S.; Divall S.; Nwaopara A.; Radovick S.; Wondisford F.; Ko C.; Wolfe A.; Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes  2014,63(4),1270-1282","journal-title":"Diabetes"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3390\/nu13061848","volume":"13","author":"Calcaterra V.","year":"2021","unstructured":"Calcaterra V.; Verduci E.; Cena H.; Magenes V.C.; Todisco C.F.; Tenuta E.; Gregorio C.; De Giuseppe R.; Bosetti A.; Di Profio E.; Zuccotti G.; Polycystic ovary syndrome in insulin\u2010resistant adolescents with obesity: The role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients  2021,13(6),1848","journal-title":"Nutrients"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"Li T.","year":"2017","unstructured":"Li T.; Mo H.; Chen W.; Li L.; Xiao Y.; Zhang J.; Li X.; Lu Y.; Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci  2017,24(5),646-655","journal-title":"Reprod Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12958-021-00760-x","volume":"19","author":"Si C.","year":"2021","unstructured":"Si C.; Wang N.; Wang M.; Liu Y.; Niu Z.; Ding Z.; TMT-based proteomic and bioinformatic analyses of human granulosa cells from obese and normal-weight female subjects. Reprod Biol Endocrinol  2021,19(1),75","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"Weisberg S.P.","year":"2003","unstructured":"Weisberg S.P.; McCann D.; Desai M.; Rosenbaum M.; Leibel R.L.; Ferrante A.W.; Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest  2003,112(12),1796-1808","journal-title":"J Clin Invest"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/ijo.2016.154","volume":"40","author":"Or\u00f3stica L.","year":"2016","unstructured":"Or\u00f3stica L.; Astorga I.; Plaza-Parrochia F.; Vera C.; Garc\u00eda V.; Carvajal R.; Gabler F.; Romero C.; Vega M.; Proinflammatory environment and role of TNF-\u03b1 in endometrial function of obese women having polycystic ovarian syndrome. Int J Obes  2016,40(11),1715-1722","journal-title":"Int J Obes"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nm1185","volume":"11","author":"Arkan M.C.","year":"2005","unstructured":"Arkan M.C.; Hevener A.L.; Greten F.R.; Maeda S.; Li Z.W.; Long J.M.; Wynshaw-Boris A.; Poli G.; Olefsky J.; Karin M.; IKK-\u03b2 links inflammation to obesity-induced insulin resistance. Nat Med  2005,11(2),191-198","journal-title":"Nat Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"923073","DOI":"10.12659\/MSM.923073","volume":"26","author":"Xu J.","year":"2020","unstructured":"Xu J.; Dun J.; Yang J.; Zhang J.; Lin Q.; Huang M.; Ji F.; Huang L.; You X.; Lin Y.; Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monit  2020,26,923073","journal-title":"Med Sci Monit"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1210\/en.2019-00487","volume":"160","author":"Lainez N.M.","year":"2019","unstructured":"Lainez N.M.; Coss D.; Obesity, neuroinflammation, and reproductive function. Endocrinology  2019,160(11),2719-2736","journal-title":"Endocrinology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"118310","DOI":"10.1016\/j.lfs.2020.118310","volume":"260","author":"Liu Q.","year":"2020","unstructured":"Liu Q.; Jiang J.; Shi Y.; Mo Z.; Li M.; Apelin\/Apelin receptor: A new therapeutic target in Polycystic Ovary Syndrome. Life Sci  2020,260,118310","journal-title":"Life Sci"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cca.2020.04.009","volume":"507","author":"Su X.","year":"2020","unstructured":"Su X.; Peng D.; Adipokines as novel biomarkers of cardio-metabolic disorders. Clin Chim Acta  2020,507,31-38","journal-title":"Clin Chim Acta"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12958-018-0336-z","volume":"16","author":"Silvestris E.","year":"2018","unstructured":"Silvestris E.; de Pergola G.; Rosania R.; Loverro G.; Obesity as disruptor of the female fertility. Reprod Biol Endocrinol  2018,16(1),22","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1210\/jc.2016-1659","volume":"101","author":"Legro R.S.","year":"2016","unstructured":"Legro R.S.; Dodson W.C.; Kunselman A.R.; Stetter C.M.; Kris-Etherton P.M.; Williams N.I.; Gnatuk C.L.; Estes S.J.; Allison K.C.; Sarwer D.B.; Diamond M.P.; Schlaff W.D.; Casson P.R.; Christman G.M.; Barnhart K.T.; Bates G.W.; Usadi R.; Lucidi S.; Baker V.; Zhang H.; Eisenberg E.; Coutifaris C.; Dokras A.; Benefit of delayed fertility therapy with preconception weight loss over immediate therapy in obese women with PCOS. J Clin Endocrinol Metab  2016,101(7),2658-2666","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","volume":"27","author":"Gustafson B.","year":"2007","unstructured":"Gustafson B.; Hammarstedt A.; Andersson C.X.; Smith U.; Inflamed adipose tissue: A culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol  2007,27(11),2276-2283","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","volume":"51","author":"Ek I.","year":"2002","unstructured":"Ek I.; Arner P.; Ryd\u00e9n M.; Holm C.; Th\u00f6rne A.; Hoffstedt J.; Wahrenberg H.; A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes  2002,51(2),484-492","journal-title":"Diabetes"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"Rudnicka E.","year":"2021","unstructured":"Rudnicka E.; Suchta K.; Grymowicz M.; Calik-Ksepka A.; Smolarczyk K.; Duszewska A.M.; Smolarczyk R.; Meczekalski B.; Chronic low grade inflammation in pathogenesis of pcos. Int J Mol Sci  2021,22(7),3789","journal-title":"Int J Mol Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"685724","DOI":"10.3389\/fimmu.2021.685724","volume":"12","author":"Liu Y.","year":"2021","unstructured":"Liu Y.; Liu H.; Li Z.; Fan H.; Yan X.; Liu X.; Xuan J.; Feng D.; Wei X.; The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front Immunol  2021,12,685724","journal-title":"Front Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/ijms22052734","volume":"22","author":"Aboeldalyl S.","year":"2021","unstructured":"Aboeldalyl S.; James C.; Seyam E.; Ibrahim E.M.; Shawki H.E.D.; Amer S.; The role of chronic inflammation in polycystic ovarian syndrome\u2014a systematic review and meta-analysis. Int J Mol Sci  2021,22(5),2734","journal-title":"Int J Mol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcp.29912","volume":"236","author":"Rostamtabar M.","year":"2021","unstructured":"Rostamtabar M.; Esmaeilzadeh S.; Tourani M.; Rahmani A.; Baee M.; Shirafkan F.; Saleki K.; Mirzababayi S.S.; Ebrahimpour S.; Nouri H.R.; Pathophysiological roles of chronic low\u2010grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol  2021,236(2),824-838","journal-title":"J Cell Physiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"112870","DOI":"10.1016\/j.biopha.2022.112870","volume":"149","author":"Ibrahim Y.F.","year":"2022","unstructured":"Ibrahim Y.F.; Alorabi M.; Abdelzaher W.Y.; Toni N.D.M.; Thabet K.; Hegazy A.; Bahaa H.A.; Batiha G.E.S.; Welson N.N.; Morsy M.A.; Venugopala K.N.; Abdel-Aziz A.M.; Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother  2022,149,112870","journal-title":"Biomed Pharmacother"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4092470","DOI":"10.1155\/2020\/4092470","volume":"2020","author":"Rudnicka E.","year":"2020","unstructured":"Rudnicka E.; Kunicki M.; Suchta K.; Machura P.; Grymowicz M.; Smolarczyk R.; Inflammatory markers in women with polycystic ovary syndrome. BioMed Res Int  2020,2020(1),4092470","journal-title":"BioMed Res Int"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"141049","DOI":"10.1016\/j.scitotenv.2020.141049","volume":"745","author":"Wang D.","year":"2020","unstructured":"Wang D.; Weng Y.; Zhang Y.; Wang R.; Wang T.; Zhou J.; Shen S.; Wang H.; Wang Y.; Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ  2020,745,141049","journal-title":"Sci Total Environ"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijpvm.IJPVM_576_17","volume":"10","author":"Mohammadi M.","year":"2019","unstructured":"Mohammadi M.; Oxidative stress and polycystic ovary syndrome: A brief review. Int J Prev Med  2019,10(1),86","journal-title":"Int J Prev Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2305-0500.275523","volume":"9","author":"Oyebanji O.","year":"2020","unstructured":"Oyebanji O.; Asaolu M.; Assessment of antioxidant status of women with polycystic ovarian syndrome. Asian Pac J Reprod  2020,9(1),9-15","journal-title":"Asian Pac J Reprod"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12958-024-01337-0","volume":"22","author":"Yan H.","year":"2024","unstructured":"Yan H.; Wang L.; Zhang G.; Li N.; Zhao Y.; Liu J.; Jiang M.; Du X.; Zeng Q.; Xiong D.; He L.; Zhou Z.; Luo M.; Liu W.; Oxidative stress and energy metabolism abnormalities in polycystic ovary syndrome: From mechanisms to therapeutic strategies. Reprod Biol Endocrinol  2024,22(1),159","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=60","first-page":"187","volume":"48","author":"Forghani N.","year":"2023","unstructured":"Forghani N.; Karimi Z.; Mokhtari M.; Shariati M.; Masjedi F.; Association of oxidative stress with kidney injury in a hyperandrogenemic female rat model. Iran J Med Sci  2023,48(2),187-197","journal-title":"Iran J Med Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10815-020-02014-y","volume":"38","author":"Liu Y.","year":"2023","unstructured":"Liu Y.; Yu Z.; Zhao S.; Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality. J Assist Reprod Genet  2023,38(2),471-477","journal-title":"J Assist Reprod Genet"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.fertnstert.2021.07.1203","volume":"116","author":"Sun Y.","year":"2021","unstructured":"Sun Y.; Li S.; Liu H.; Bai H.; Hu K.; Zhang R.; Liu Q.; Fan P.; Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome. Fertil Steril  2021,116(6),1641-1650","journal-title":"Fertil Steril"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3849692","DOI":"10.1155\/2019\/3849692","volume":"2019","author":"Sztretye M.","year":"2019","unstructured":"Sztretye M.; Dienes B.; G\u00f6nczi M.; Astaxanthin: A potential mitochondrial-targeted antioxidant treatment in diseases and with aging. Oxid Med Cell Longev  2019,2019,3849692","journal-title":"Oxid Med Cell Longev"},{"key":"ref=64","first-page":"1","volume":"13","author":"Amini L.","year":"2015","unstructured":"Amini L.; Tehranian N.; Movahedin M.; Ramezani Tehrani F.; Ziaee S.; Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials. Iran J Reprod Med  2015,13(1),1-8","journal-title":"Iran J Reprod Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"Murri M.","year":"2013","unstructured":"Murri M.; Luque-Ram\u00edrez M.; Insenser M.; Ojeda-Ojeda M.; Escobar-Morreale H.F.; Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Hum Reprod Update  2013,19(3),268-288","journal-title":"Hum Reprod Update"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"bqae023","DOI":"10.1210\/endocr\/bqae023","volume":"165","author":"Dai M.","year":"2024","unstructured":"Dai M.; Hong L.; Yin T.; Liu S.; Disturbed follicular microenvironment in polycystic ovary syndrome: Relationship to oocyte quality and infertility. Endocrinology  2024,165(4),bqae023","journal-title":"Endocrinology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.dsx.2019.04.032","volume":"13","author":"Fatima Q.","year":"2019","unstructured":"Fatima Q.; Amin S.; Kawa I.A.; Jeelani H.; Manzoor S.; Rizvi S.M.; Rashid F.; Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study. Diabetes Metab Syndr  2019,13(3),1957-1961","journal-title":"Diabetes Metab Syndr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3390\/antiox12122117","volume":"12","author":"Chen Y.","year":"2023","unstructured":"Chen Y.; Yang J.; Zhang L.; The impact of follicular fluid oxidative stress levels on the outcomes of assisted reproductive therapy. Antioxidants  2023,12(12),2117","journal-title":"Antioxidants"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/GRF.0000000000000581","volume":"64","author":"Combs J.C.","year":"2021","unstructured":"Combs J.C.; Hill M.J.; Decherney A.H.; Polycystic ovarian syndrome genetics and epigenetics. Clin Obstet Gynecol  2021,64(1),20-25","journal-title":"Clin Obstet Gynecol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/TACG.S200341","volume":"12","author":"Khan M.J.","year":"2019","unstructured":"Khan M.J.; Ullah A.; Basit S.; Genetic basis of polycystic ovary syndrome (PCOS): Current perspectives. Appl Clin Genet  2019,12,249-260","journal-title":"Appl Clin Genet"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"664843","DOI":"10.3389\/fcell.2021.664843","volume":"9","author":"Cao P.","year":"2021","unstructured":"Cao P.; Yang W.; Wang P.; Li X.; Nashun B.; Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome. Front Cell Dev Biol  2021,9,664843","journal-title":"Front Cell Dev Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.reprotox.2018.09.006","volume":"82","author":"Konieczna A.","year":"2018","unstructured":"Konieczna A.; Racho\u0144 D.; Owczarek K.; Kubica P.; Kowalewska A.; Kud\u0142ak B.; Wasik A.; Namie\u015bnik J.; Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome. Reprod Toxicol  2018,82,32-37","journal-title":"Reprod Toxicol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25259\/JRHM_16_2021","volume":"3","author":"Kumar R.","year":"2022","unstructured":"Kumar R.; Minerva S.; Shah R.; Bhat A.; Verma S.; Chander G.; Bhat G.R.; Thapa N.; Bhat A.; Wakhloo A.; Ganie M.A.; Role of genetic, environmental, and hormonal factors in the progression of PCOS: A review. J Reprod Health Med  2022,3,3","journal-title":"J Reprod Health Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"67925","DOI":"10.1007\/s11356-021-16489-4","volume":"28","author":"Priya K.","year":"2021","unstructured":"Priya K.; Setty M.; Babu U.V.; Pai K.S.R.; Implications of environmental toxicants on ovarian follicles: How it can adversely affect the female fertility? Environ Sci Pollut Res Int  2021,28(48),67925-67939","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1091147","DOI":"10.3389\/fendo.2022.1091147","volume":"13","author":"Tong C.","year":"2022","unstructured":"Tong C.; Wu Y.; Zhang L.; Yu Y.; Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway. Front Endocrinol  2022,13,1091147","journal-title":"Front Endocrinol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"E2016","DOI":"10.1210\/jc.2011-3441","volume":"97","author":"Kaur S.","year":"2012","unstructured":"Kaur S.; Archer K.J.; Devi M.G.; Kriplani A.; Strauss J.F.; Singh R.; Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: Identification of susceptibility gene sets through network analysis. J Clin Endocrinol Metab  2012,97(10),E2016-E2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1191759","DOI":"10.3389\/fendo.2023.1191759","volume":"14","author":"Wang K.","year":"2023","unstructured":"Wang K.; Li Y.; Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol  2023,14,1191759","journal-title":"Front Endocrinol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1002429","DOI":"10.1371\/journal.pgen.1002429","volume":"7","author":"Zhang W.","year":"2011","unstructured":"Zhang W.; Thompson B.J.; Hietakangas V.; Cohen S.M.; MAPK\/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet  2011,7(12),1002429","journal-title":"PLoS Genet"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"779718","DOI":"10.3389\/fcell.2021.779718","volume":"9","author":"Gao Y.","year":"2021","unstructured":"Gao Y.; Chen J.; Ji R.; Ding J.; Zhang Y.; Yang J.; USP25 regulates the proliferation and apoptosis of ovarian granulosa cells in polycystic ovary syndrome by modulating the pi3k\/akt pathway via deubiquitinating PTEN. Front Cell Dev Biol  2021,9,779718","journal-title":"Front Cell Dev Biol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"118003","DOI":"10.1016\/j.lfs.2020.118003","volume":"256","author":"Abuelezz N.Z.","year":"2020","unstructured":"Abuelezz N.Z.; Shabana M.E.; Abdel-Mageed H.M.; Rashed L.; Morcos G.N.B.; Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K\/AkT\/mTOR and TNF-\u03b1 modulations. Life Sci  2020,256,118003","journal-title":"Life Sci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.3390\/ijms22189838","volume":"22","author":"De Felici M.","year":"2021","unstructured":"De Felici M.; Klinger F.G.; Pi3k\/pten\/akt signaling pathways in germ cell development and their involvement in germ cell tumors and ovarian dysfunctions. Int J Mol Sci  2021,22(18),9838","journal-title":"Int J Mol Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12958-020-00677-x","volume":"18","author":"Gong Y.","year":"2020","unstructured":"Gong Y.; Luo S.; Fan P.; Zhu H.; Li Y.; Huang W.; Growth hormone activates PI3K\/Akt signaling and inhibits ROS accumulation and apoptosis in granulosa cells of patients with polycystic ovary syndrome. Reprod Biol Endocrinol  2020,18(1),121","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.repbio.2021.100594","volume":"22","author":"Guo R.","year":"2022","unstructured":"Guo R.; Zheng H.; Li Q.; Qiu X.; Zhang J.; Cheng Z.; Melatonin alleviates insulin resistance through the PI3K\/AKT signaling pathway in ovary granulosa cells of polycystic ovary syndrome. Reprod Biol  2022,22(1),100594","journal-title":"Reprod Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"20889","DOI":"10.1016\/j.heliyon.2023.e20889","volume":"9","author":"Jung W.","year":"2023","unstructured":"Jung W.; Choi H.; Kim J.; Kim J.; Kim W.; Nurkolis F.; Kim B.; Effects of natural products on polycystic ovary syndrome: From traditional medicine to modern drug discovery. Heliyon  2023,9(10),20889","journal-title":"Heliyon"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2160569","DOI":"10.1080\/13510002.2022.2160569","volume":"28","author":"Rabah H.M.","year":"2023","unstructured":"Rabah H.M.; Mohamed D.A.; Mariah R.A.; Abd El-Khalik S.R.; Khattab H.A.; AbuoHashish N.A.; Abdelsattar A.M.; Raslan M.A.; Farghal E.E.; Eltokhy A.K.; Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: Targeting PI3K\/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue. Redox Rep  2023,28(1),2160569","journal-title":"Redox Rep"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"7982","DOI":"10.1038\/s41598-018-26210-0","volume":"8","author":"Wu C.","year":"2018","unstructured":"Wu C.; Jiang F.; Wei K.; Jiang Z.; Exercise activates the PI3K-AKT signal pathway by decreasing the expression of 5\u03b1-reductase type 1 in PCOS rats. Sci Rep  2018,8(1),7982","journal-title":"Sci Rep"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/REP-13-0386","volume":"147","author":"Choi J.","year":"2014","unstructured":"Choi J.; Jo M.; Lee E.; Choi D.; AKT is involved in granulosa cell autophagy regulation via mTOR signaling during rat follicular development and atresia. Reproduction  2014,147(1),73-80","journal-title":"Reproduction"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/REP-17-0499","volume":"155","author":"Li D.","year":"2018","unstructured":"Li D.; You Y.; Bi F.F.; Zhang T.N.; Jiao J.; Wang T.R.; Zhou Y.M.; Shen Z.Q.; Wang X.X.; Yang Q.; Autophagy is activated in the ovarian tissue of polycystic ovary syndrome. Reproduction  2018,155(1),85-92","journal-title":"Reproduction"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1757-2215-2-17","volume":"2","author":"Fukuda S.","year":"2009","unstructured":"Fukuda S.; Orisaka M.; Tajima K.; Hattori K.; Kotsuji F.; Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP Kinase in bovine theca cells. J Ovarian Res  2009,2(1),17","journal-title":"J Ovarian Res"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13048-025-01663-w","volume":"18","author":"Yuanyuan C.","year":"2025","unstructured":"Yuanyuan C.; Ningyu S.; Lu L.; Wuwen Z.; Kai L.; Yanting L.; Junlan H.; Xiang C.; Jing Z.; Hua Y.; Ping Y.; Transcriptomic analysis of theca cells in a PCOS rat model: Insights into follicular development. J Ovarian Res  2025,18(1),135","journal-title":"J Ovarian Res"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"Diamanti-Kandarakis E.","year":"2012","unstructured":"Diamanti-Kandarakis E.; Dunaif A.; Insulin resistance and the polycystic ovary syndrome revisited: An update on mechanisms and implications. Endocr Rev  2012,33(6),981-1030","journal-title":"Endocr Rev"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2018.10.042","volume":"684","author":"Liang Y.J.","year":"2019","unstructured":"Liang Y.J.; Yang W.X.; Kinesins in MAPK cascade: How kinesin motors are involved in the MAPK pathway? Gene  2019,684,1-9","journal-title":"Gene"},{"key":"ref=93","author":"Zhang W.","year":"2002","unstructured":"Zhang W.; Liu H.T.; Tu H.; Cell research.  Available from:  http:\/\/www.cell-research.com2002"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26502\/jbb.2642-91280066","volume":"6","author":"Seger R.","year":"2023","unstructured":"Seger R.; Hanoch T.; Rosenberg R.; Dantes A.; Merz W.E.; Strauss J.F.; Amsterdam A.; The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biotech Biomed  2023,6(1),1-12","journal-title":"J Biotech Biomed"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.3390\/ijms24119205","volume":"24","author":"Liu S.","year":"2023","unstructured":"Liu S.; Jia Y.; Meng S.; Luo Y.; Yang Q.; Pan Z.; Mechanisms of and potential medications for oxidative stress in ovarian granulosa cells: A review. Int J Mol Sci  2023,24(11),9205","journal-title":"Int J Mol Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"13663","DOI":"10.1111\/aji.13663","volume":"89","author":"Guo F.","year":"2023","unstructured":"Guo F.; Fernando T.; Zhu X.; Shi Y.; The overexpression of neurokinin B\u2013neurokinin 3 receptor system exerts direct effects on the ovary under PCOS\u2010like conditions to interfere with mitochondrial function. Am J Reprod Immunol  2023,89(3),13663","journal-title":"Am J Reprod Immunol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"787876","DOI":"10.3389\/fendo.2022.787876","volume":"13","author":"Liu Y.","year":"2022","unstructured":"Liu Y.; Li Z.; Wang Y.; Cai Q.; Liu H.; Xu C.; Zhang F.; IL-15 participates in the pathogenesis of polycystic ovary syndrome by affecting the activity of granulosa cells. Front Endocrinol  2022,13,787876","journal-title":"Front Endocrinol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"110841","DOI":"10.1016\/j.intimp.2023.110841","volume":"124","author":"Ding L.","year":"2023","unstructured":"Ding L.; Jiang L.; Xing Z.; Dai H.; Wei J.; Map4k4 is up-regulated and modulates granulosa cell injury and oxidative stress in polycystic ovary syndrome via activating JNK\/c-JUN pathway: An experimental study. Int Immunopharmacol  2023,124(Pt A),110841","journal-title":"Int Immunopharmacol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.mce.2020.110792","volume":"508","author":"Kobayashi M.","year":"2020","unstructured":"Kobayashi M.; Yoshino O.; Nakashima A.; Ito M.; Nishio K.; Ono Y.; Kusabiraki T.; Kunitomi C.; Takahashi N.; Harada M.; Hattori K.; Orisaka M.; Osuga Y.; Saito S.; Inhibition of autophagy in theca cells induces CYP17A1 and PAI-1 expression via ROS\/p38 and JNK signalling during the development of polycystic ovary syndrome. Mol Cell Endocrinol  2020,508,110792","journal-title":"Mol Cell Endocrinol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"104544","DOI":"10.1016\/j.yrtph.2019.104544","volume":"110","author":"Zhang N.","year":"2020","unstructured":"Zhang N.; Liu X.; Zhuang L.; Liu X.; Zhao H.; Shan Y.; Liu Z.; Li F.; Wang Y.; Fang J.; Berberine decreases insulin resistance in a PCOS rats by improving GLUT4: Dual regulation of the PI3K\/AKT and MAPK pathways. Regul Toxicol Pharmacol  2020,110,104544","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/humrep\/deaa077","volume":"35","author":"Jin J.","year":"2020","unstructured":"Jin J.; Ma Y.; Tong X.; Yang W.; Dai Y.; Pan Y.; Ren P.; Liu L.; Fan H.Y.; Zhang Y.; Zhang S.; Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod  2020,35(5),1145-1158","journal-title":"Hum Reprod"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"14994","DOI":"10.1038\/srep14994","volume":"5","author":"Lan C.W.","year":"2015","unstructured":"Lan C.W.; Chen M.J.; Tai K.Y.; Yu D.C.W.; Yang Y.C.; Jan P.S.; Yang Y.S.; Chen H.F.; Ho H.N.; Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK\/ERK signaling. Sci Rep  2015,5(1),14994","journal-title":"Sci Rep"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1074\/jbc.M115.705368","volume":"291","author":"Donaubauer E.M.","year":"2016","unstructured":"Donaubauer E.M.; Hunzicker-Dunn M.E.; Extracellular Signal-regulated Kinase (ERK)-dependent phosphorylation of Y-Box-binding protein 1 (YB-1) enhances gene expression in granulosa cells in response to follicle-stimulating hormone (FSH). J Biol Chem  2016,291(23),12145-12160","journal-title":"J Biol Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"111965","DOI":"10.1016\/j.jep.2019.111965","volume":"250","author":"Qiu Z.","year":"2020","unstructured":"Qiu Z.; Dong J.; Xue C.; Li X.; Liu K.; Liu B.; Cheng J.; Huang F.; Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K\/Akt signaling pathway. J Ethnopharmacol  2020,250,111965","journal-title":"J Ethnopharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13048-025-01737-9","volume":"18","author":"Zhao H.","year":"2025","unstructured":"Zhao H.; Dinh T.H.; Wang Y.; Yang Y.; The roles of MAPK signaling pathway in ovarian folliculogenesis. J Ovarian Res  2025,18(1),152","journal-title":"J Ovarian Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Liu T.","year":"2017","unstructured":"Liu T.; Zhang L.; Joo D.; Sun S.C.; NF-\u03baB signaling in inflammation. Signal Transduct Target Ther  2017,2,17023","journal-title":"Signal Transduct Target Ther"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11010-023-04736-w","volume":"479","author":"Tan W.","year":"2024","unstructured":"Tan W.; Zhang J.; Dai F.; Yang D.; Gu R.; Tang L.; Liu H.; Cheng Y.; Insights on the NF-\u03baB system in polycystic ovary syndrome, attractive therapeutic targets. Mol Cell Biochem  2024,479(3),467-486","journal-title":"Mol Cell Biochem"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"Lawrence T.","year":"2009","unstructured":"Lawrence T.; The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol  2009,1(6),a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/09513590.2012.683082","volume":"28","author":"Deligeoroglou E.","year":"2012","unstructured":"Deligeoroglou E.; Vrachnis N.; Athanasopoulos N.; Iliodromiti Z.; Sifakis S.; Iliodromiti S.; Siristatidis C.; Creatsas G.; Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol  2012,28(12),974-978","journal-title":"Gynecol Endocrinol"},{"key":"ref=110","first-page":"965","volume":"72","author":"Ha L.X.","year":"2021","unstructured":"Ha L.X.; Wu Y.Y.; Yin T.; Yuan Y.Y.; Du Y.D.; Effect of TNF-alpha on endometrial glucose transporter-4 expression in patients with polycystic ovary syndrome through nuclear factor-kappa B signaling pathway activation. J Physiol Pharmacol  2021,72(6),965-973","journal-title":"J Physiol Pharmacol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"155632","DOI":"10.1016\/j.cyto.2021.155632","volume":"146","author":"He Z.","year":"2021","unstructured":"He Z.; Wang Y.; Zhuan L.; Li Y.; Tang Z.; Wu Z.; Ma Y.; MIF-mediated NF-\u03baB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats. Cytokine  2021,146,155632","journal-title":"Cytokine"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Guo Q.","year":"2024","unstructured":"Guo Q.; Jin Y.; Chen X.; Ye X.; Shen X.; Lin M.; Zeng C.; Zhou T.; Zhang J.; NF-\u03baB in biology and targeted therapy: New insights and translational implications. Signal Transduct Target Ther  2024,9(1),53","journal-title":"Signal Transduct Target Ther"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"967151","DOI":"10.3389\/fimmu.2022.967151","volume":"13","author":"Tan W.","year":"2022","unstructured":"Tan W.; Dai F.; Yang D.; Deng Z.; Gu R.; Zhao X.; Cheng Y.; MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome. Front Immunol  2022,13,967151","journal-title":"Front Immunol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1080\/01443615.2017.1315563","volume":"37","author":"Koc O.","year":"2017","unstructured":"Koc O.; Ozdemirici S.; Acet M.; Soyturk U.; Aydin S.; Nuclear factor-\u03baB expression in the endometrium of normal and overweight women with polycystic ovary syndrome. J Obstet Gynaecol  2017,37(7),924-930","journal-title":"J Obstet Gynaecol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"Ahmed S.M.U.","year":"2017","unstructured":"Ahmed S.M.U.; Luo L.; Namani A.; Wang X.J.; Tang X.; Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis  2017,1863(2),585-597","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-025-01639-w","volume":"18","author":"Ghantabpour T.","year":"2025","unstructured":"Ghantabpour T.; Goudarzi N.; Parsaei H.; Overview of Nrf2 as a target in ovary and ovarian dysfunctions focusing on its antioxidant properties. J Ovarian Res  2025,18(1),60","journal-title":"J Ovarian Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"e00099-20","DOI":"10.1128\/MCB.00099-20","volume":"40","author":"Baird L.","year":"2020","unstructured":"Baird L.; Yamamoto M.; The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol  2020,40(13),e00099-20","journal-title":"Mol Cell Biol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4350965","DOI":"10.1155\/2016\/4350965","volume":"2016","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Wang X.; Vikash V.; Ye Q.; Wu D.; Liu Y.; Dong W.; ROS and ROS\u2010mediated cellular signaling. Oxid Med Cell Longev  2016,2016(1),4350965","journal-title":"Oxid Med Cell Longev"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12958-018-0391-5","volume":"16","author":"Lu J.","year":"2018","unstructured":"Lu J.; Wang Z.; Cao J.; Chen Y.; Dong Y.; A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol  2018,16(1),80","journal-title":"Reprod Biol Endocrinol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cbi.2017.06.009","volume":"273","author":"Kabel A.M.","year":"2017","unstructured":"Kabel A.M.; Al-Shehri A.H.; Al-Talhi R.A.; Abd Elmaaboud M.A.; The promising effect of linagliptin and\/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome. Chem Biol Interact  2017,273,190-199","journal-title":"Chem Biol Interact"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbamcr.2008.01.002","volume":"1783","author":"Liu G.H.","year":"2008","unstructured":"Liu G.H.; Qu J.; Shen X.; NF-\u03baB\/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta Mol Cell Res  2008,1783(5),713-727","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/molecules24071377","volume":"24","author":"Armagan G.","year":"2019","unstructured":"Armagan G.; Sevgili E.; G\u00fcrkan F.T.; K\u00f6se F.A.; Bilgi\u00e7 T.; Dagc\u0131 T.; Saso L.; Regulation of the Nrf2 pathway by glycogen synthase kinase-3\u03b2 in MPP+-induced cell damage. Molecules  2019,24(7),1377","journal-title":"Molecules"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"38553","DOI":"10.1038\/srep38553","volume":"6","author":"Medunjanin S.","year":"2016","unstructured":"Medunjanin S.; Schleithoff L.; Fiegehenn C.; Weinert S.; Zuschratter W.; Braun-Dullaeus R.C.; GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO. Sci Rep  2016,6(1),38553","journal-title":"Sci Rep"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"Saha S.","year":"2020","unstructured":"Saha S.; Buttari B.; Panieri E.; Profumo E.; Saso L.; An overview of Nrf2 signaling pathway and its role in inflammation. Molecules  2020,25(22),5474","journal-title":"Molecules"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/hep.31116","volume":"71","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Liu K.; Zhang J.; Hai Y.; Wang P.; Wang H.; Liu Q.; Wong C.C.L.; Yao J.; Gao Y.; Liao Y.; Tang X.; Wang X.J.; c\u2010Jun NH2\u2010terminal protein kinase phosphorylates the nrf2\u2010ech homology 6 domain of nuclear factor erythroid 2\u2013related factor 2 and downregulates cytoprotective genes in acetaminophen\u2010induced liver injury in mice. Hepatology  2020,71(5),1787-1801","journal-title":"Hepatology"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1007\/s12011-023-03579-2","volume":"201","author":"Butt M.A.","year":"2023","unstructured":"Butt M.A.; Shafique H.M.; Mustafa M.; Moghul N.B.; Munir A.; Shamas U.; Tabassum S.; Kiyani M.M.; Therapeutic potential of selenium nanoparticles on letrozole-induced polycystic ovarian syndrome in female wistar rats. Biol Trace Elem Res  2023,201(11),5213-5229","journal-title":"Biol Trace Elem Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"04279","DOI":"10.1016\/j.heliyon.2020.e04279","volume":"6","author":"Kyei G.","year":"2020","unstructured":"Kyei G.; Sobhani A.; Nekonam S.; Shabani M.; Ebrahimi F.; Qasemi M.; Salahi E.; Fardin A.; Assessing the effect of MitoQ10 and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model. Heliyon  2020,6(7),04279","journal-title":"Heliyon"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8218650","volume":"2019","author":"Yu K.","year":"2019","unstructured":"Yu K.; Wang R.X.; Li M.H.; Sun T.C.; Zhou Y.W.; Li Y.Y.; Sun L.H.; Zhang B.L.; Lian Z.X.; Xue S.G.; Liu Y.X.; Deng S.L.; Melatonin reduces androgen production and upregulates heme oxygenase-1 expression in granulosa cells from pcos patients with hypoestrogenia and hyperandrogenia. Oxid Med Cell Longev  2019,2019,1-13","journal-title":"Oxid Med Cell Longev"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"gaaa081","DOI":"10.1093\/molehr\/gaaa081","volume":"27","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Li N.; Zeng Z.; Tang L.; Zhao S.; Zhou F.; Zhou L.; Xia W.; Zhu C.; Rao M.; Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1\/Nrf2 pathway. Mol Hum Reprod  2021,27(2),gaaa081","journal-title":"Mol Hum Reprod"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"E1085","DOI":"10.1152\/ajpendo.00034.2021","volume":"320","author":"Huang Y.","year":"2021","unstructured":"Huang Y.; Zhang X.; Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress. Am J Physiol Endocrinol Metab  2021,320(6),E1085-E1092","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1626938","DOI":"10.3389\/fcell.2025.1626938","volume":"13","author":"Qu J.","year":"2025","unstructured":"Qu J.; Qiu M.; Wang J.; Chen Z.; Chen M.; Teng X.; Li Y.; Fibroblast growth factor 19 regulates polycystic ovary syndrome progression via FGFR4-ERK-NRF2 pathway. Front Cell Dev Biol  2025,13,1626938","journal-title":"Front Cell Dev Biol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"Loboda A.","year":"2016","unstructured":"Loboda A.; Damulewicz M.; Pyza E.; Jozkowicz A.; Dulak J.; Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cell Mol Life Sci  2016,73(17),3221-3247","journal-title":"Cell Mol Life Sci"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4049\/immunohorizons.2200033","volume":"7","author":"Banerjee S.","year":"2023","unstructured":"Banerjee S.; Cooney L.G.; Stanic A.K.; Immune dysfunction in polycystic ovary syndrome. Immunohorizons  2023,7(5),323-332","journal-title":"Immunohorizons"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"103776","DOI":"10.1016\/j.redox.2025.103776","volume":"85","author":"Liu H.","year":"2025","unstructured":"Liu H.; Jin L.; Wang X.; Shi J.; He Y.; Sun N.; Yang F.; Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities. Redox Biol  2025,85,103776","journal-title":"Redox Biol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00441-021-03445-4","volume":"385","author":"Taqi M.O.","year":"2021","unstructured":"Taqi M.O.; Saeed-Zidane M.; Gebremedhn S.; Salilew-Wondim D.; Tholen E.; Neuhoff C.; Hoelker M.; Schellander K.; Tesfaye D.; NRF2-mediated signaling is a master regulator of transcription factors in bovine granulosa cells under oxidative stress condition. Cell Tissue Res  2021,385(3),769-783","journal-title":"Cell Tissue Res"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1520695","DOI":"10.3389\/fnut.2025.1520695","volume":"12","author":"Yuan J.","year":"2025","unstructured":"Yuan J.; Li Z.; Yu Y.; Wang X.; Zhao Y.; Natural compounds in the management of polycystic ovary syndrome: A comprehensive review of hormonal regulation and therapeutic potential. Front Nutr  2025,12,1520695","journal-title":"Front Nutr"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1210\/jc.2012-1259","volume":"97","author":"Gonz\u00e1lez F.","year":"2012","unstructured":"Gonz\u00e1lez F.; Nair K.S.; Daniels J.K.; Basal E.; Schimke J.M.; Blair H.E.; Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab  2012,97(8),2836-2843","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1007\/s12020-024-03726-2","volume":"84","author":"Zhang R.","year":"2024","unstructured":"Zhang R.; Hu K.; Bai H.; Liu H.; Pu Y.; Yang C.; Liu Q.; Fan P.; Increased oxidative stress is associated with hyperandrogenemia in polycystic ovary syndrome evidenced by oxidized lipoproteins stimulating rat ovarian androgen synthesis in vitro. Endocrine  2024,84(3),1238-1249","journal-title":"Endocrine"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","volume":"77","author":"Gonz\u00e1lez F.","year":"2012","unstructured":"Gonz\u00e1lez F.; Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction. Steroids  2012,77(4),300-305","journal-title":"Steroids"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","volume":"14","author":"Xing C.","year":"2022","unstructured":"Xing C.; Zhang J.; Zhao H.; He B.; Effect of sex hormone-binding globulin on polycystic ovary syndrome: Mechanisms, manifestations, genetics, and treatment. Int J Womens Health  2022,14,91-105","journal-title":"Int J Womens Health"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12964-023-01410-y","volume":"22","author":"Shi J.","year":"2024","unstructured":"Shi J.; Hu K.L.; Li X.X.; Ge Y.M.; Yu X.J.; Zhao J.; Bisphenol a downregulates GLUT4 expression by activating aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome. Cell Commun Signal  2024,22(1),28","journal-title":"Cell Commun Signal"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/tox.22702","volume":"34","author":"Huang F.M.","year":"2019","unstructured":"Huang F.M.; Chang Y.C.; Lee S.S.; Yang M.L.; Kuan Y.H.; Expression of pro\u2010inflammatory cytokines and mediators induced by Bisphenol A via ERK\u2010NF\u03baB and JAK1\/2\u2010STAT3 pathways in macrophages. Environ Toxicol  2019,34(4),486-494","journal-title":"Environ Toxicol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.3390\/ijms26094081","volume":"26","author":"Celar \u0160turm D.","year":"2025","unstructured":"Celar \u0160turm D.; Re\u017een T.; Jan\u010dar N.; Virant-Klun I.; Bisphenol a disrupts steroidogenesis and induces apoptosis in human granulosa cells cultured in vitro. Int J Mol Sci  2025,26(9),4081","journal-title":"Int J Mol Sci"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/advances\/nmaa092","volume":"12","author":"Kazemi M.","year":"2021","unstructured":"Kazemi M.; Hadi A.; Pierson R.A.; Lujan M.E.; Zello G.A.; Chilibeck P.D.; Effects of dietary glycemic index and glycemic load on cardiometabolic and reproductive profiles in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Adv Nutr  2021,12(1),161-178","journal-title":"Adv Nutr"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","volume":"105","author":"Shang Y.","year":"2020","unstructured":"Shang Y.; Zhou H.; Hu M.; Feng H.; Effect of diet on insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab  2020,105(10),3346-3360","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fphys.2020.00606","volume":"11","author":"Patten R.K.","year":"2020","unstructured":"Patten R.K.; Boyle R.A.; Moholdt T.; Kiel I.; Hopkins W.G.; Harrison C.L.; Stepto N.K.; Exercise interventions in polycystic ovary syndrome: A systematic review and meta-analysis. Front Physiol  2020,11,606","journal-title":"Front Physiol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1210\/jc.2007-2437","volume":"93","author":"Martin K.A.","year":"2008","unstructured":"Martin K.A.; Chang R.J.; Ehrmann D.A.; Ibanez L.; Lobo R.A.; Rosenfield R.L.; Shapiro J.; Montori V.M.; Swiglo B.A.; Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline. J Clin Endocrinol Metab  2008,93(4),1105-1120","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/09513590.2011.583957","volume":"28","author":"Curi D.D.G.","year":"2012","unstructured":"Curi D.D.G.; Fonseca A.M.; Marcondes J.A.M.; Almeida J.A.M.; Bagnoli V.R.; Soares J.M.; Baracat E.C.; Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol Endocrinol  2012,28(3),182-185","journal-title":"Gynecol Endocrinol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fendo.2019.00394","volume":"10","author":"Sathyapalan T.","year":"2019","unstructured":"Sathyapalan T.; Hobkirk J.P.; Javed Z.; Carroll S.; Coady A.M.; Pemberton P.; Smith A.; Cianflone K.; Atkin S.L.; The effect of atorvastatin (and subsequent metformin) on adipose tissue acylation-stimulatory-protein concentration and inflammatory biomarkers in overweight\/obese women with polycystic ovary syndrome. Front Endocrinol  2019,10(JUN),394","journal-title":"Front Endocrinol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF03345529","volume":"28","author":"Zulian E.","year":"2005","unstructured":"Zulian E.; Sartorato P.; Benedini S.; Baro G.; Armanini D.; Mantero F.; Scaroni C.; Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile. J Endocrinol Invest  2005,28(3),49-53","journal-title":"J Endocrinol Invest"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jc.85.1.89","volume":"85","author":"Moghetti P.","year":"2000","unstructured":"Moghetti P.; Tosi F.; Tosti A.; Negri C.; Misciali C.; Perrone F.; Caputo M.; Muggeo M.; Castello R.; Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: A randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab  2000,85(1),89-94","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2096-2924.305930","volume":"4","author":"Tian Q.J.","year":"2020","unstructured":"Tian Q.J.; Consensus on infertility management and fertility preservation related to polycystic ovary syndrome. Reprod Devel Med  2020,4(4),239-248","journal-title":"Reprod Devel Med"},{"key":"ref=153","first-page":"359","volume":"10","author":"Shojaeian Z.","year":"2019","unstructured":"Shojaeian Z.; Sadeghi R.; Latifnejad Roudsari R.; Calcium and vitamin D supplementation effects on metabolic factors, menstrual cycles and follicular responses in women with polycystic ocvary syndrome: A systematic review and meta-analysis. Caspian J Intern Med  2019,10(4),359-369","journal-title":"Caspian J Intern Med"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tjog.2021.11.009","volume":"61","author":"Rashid R.","year":"2022","unstructured":"Rashid R.; Mir S.A.; Kareem O.; Ali T.; Ara R.; Malik A.; Amin F.; Bader G.N.; Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwan J Obstet Gynecol  2022,61(1),40-50","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm12041454","volume":"12","author":"Singh S.","year":"2023","unstructured":"Singh S.; Pal N.; Shubham S.; Sarma D.K.; Verma V.; Marotta F.; Kumar M.; Polycystic ovary syndrome: Etiology, current management, and future therapeutics. J Clin Med  2023,12(4),1454","journal-title":"J Clin Med"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"104296","DOI":"10.1016\/j.rbmo.2024.104296","volume":"50","author":"Hu R.","year":"2025","unstructured":"Hu R.; Huang Y.; Liu Z.; Dong H.; Ma W.; Song K.; Xu X.; Wu X.; Geng Y.; Li F.; Zhang M.; Song Y.; Characteristics of polycystic ovary syndrome rat models induced by letrozole, testosterone propionate and high-fat diets. Reprod Biomed Online  2025,50(1),104296","journal-title":"Reprod Biomed Online"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"bqac164","DOI":"10.1210\/endocr\/bqac164","volume":"163","author":"Stener-Victorin E.","year":"2022","unstructured":"Stener-Victorin E.; Update on animal models of polycystic ovary syndrome. Endocrinology  2022,163(12),bqac164","journal-title":"Endocrinology"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"676133","DOI":"10.3389\/fendo.2021.676133","volume":"12","author":"Yang A.M.","year":"2021","unstructured":"Yang A.M.; Cui N.; Sun Y.F.; Hao G.M.; Letrozole for female infertility. Front Endocrinol  2021,12,676133","journal-title":"Front Endocrinol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jgg.2023.09.012","volume":"51","author":"Liu H.","year":"2024","unstructured":"Liu H.; Tu M.; Yin Z.; Zhang D.; Ma J.; He F.; Unraveling the complexity of polycystic ovary syndrome with animal models. J Genet Genomics  2024,51(2),144-158","journal-title":"J Genet Genomics"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1002\/cbf.4123","volume":"42","author":"Shah S.F.","year":"2024","unstructured":"Shah S.F.; Noorali S.; Faizi S.; Jabeen A.; Patuletin ameliorates inflammation and letrozole\u2013induced polycystic ovarian syndrome in rats. Cell Biochem Funct  2024,42(7),4123","journal-title":"Cell Biochem Funct"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/IJWH.S345853","volume":"14","author":"Cheng X.","year":"2022","unstructured":"Cheng X.; He B.; Clinical and biochemical potential of antioxidants in treating polycystic ovary syndrome. Int J Womens Health  2022,14,467-479","journal-title":"Int J Womens Health"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"ioae160","DOI":"10.1093\/biolre\/ioae160","volume":"15","author":"Wei H.","year":"2024","unstructured":"Wei H.; Zhang Z.; Zhang S.; Wang J.; Cui X.; Zhang Z.; Yu J.; Lei X.; Xiuhong Z.; Huo P.; Resveratrol improves follicular development in PCOS rats by inhibiting the inflammatory response and pyroptosis of granulosa cells. Biol Reprod  2024,15,ioae160","journal-title":"Biol Reprod"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1007\/s43032-024-01631-7","volume":"31","author":"Bai Y.","year":"2024","unstructured":"Bai Y.; Liu Y.; Wang Y.; Liu X.; Wang Y.; Liu H.; Yi H.; Xu C.; Zhang F.; IL-18BP therapy ameliorates reproductive and metabolic phenotypes in a PCOS mouse model by relieving inflammation, fibrosis and endoplasmic reticulum stress. Reprod Sci  2024,31(11),3595-3608","journal-title":"Reprod Sci"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"Siddiqui S.","year":"2022","unstructured":"Siddiqui S.; Mateen S.; Ahmad R.; Moin S.; A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet  2022,39(11),2439-2473","journal-title":"J Assist Reprod Genet"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/molecules25030549","volume":"25","author":"Jasaszwili M.","year":"2020","unstructured":"Jasaszwili M.; Billert M.; Strowski M.Z.; Nowak K.W.; Skrzypski M.; Adropin as a fat-burning hormone with multiple functions\u2014review of a decade of research. Molecules  2020,25(3),549","journal-title":"Molecules"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1113\/JP285793","volume":"602","author":"Rizk F.H.","year":"2024","unstructured":"Rizk F.H.; El Saadany A.A.; Elshamy A.M.; Abd Ellatif R.A.; El-Guindy D.M.; Helal D.S.; Hamama M.G.; El-Sharnoby J.A.E.H.; Abdel Ghafar M.T.; Faheem H.; Ameliorating effects of adropin on letrozole\u2010induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats. J Physiol  2024,602(15),3621-3639","journal-title":"J Physiol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"156639","DOI":"10.1016\/j.cyto.2024.156639","volume":"179","author":"Anima B.","year":"2024","unstructured":"Anima B.; Gurusubramanian G.; Roy V.K.; Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice. Cytokine  2024,179,156639","journal-title":"Cytokine"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"109558","DOI":"10.1016\/j.steroids.2024.109558","volume":"214","author":"Yadav S.","year":"2025","unstructured":"Yadav S.; Dadge S.; Garg R.; Goand U.K.; Agarwal A.; Chauhan D.; Gayen J.R.; Pancreastatin inhibitor PSTi8 improves ovarian health in Letrozole-HFD induced PCOS rats by ameliorating metabolic and reproductive parameters. Steroids  2025,214,109558","journal-title":"Steroids"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"973","DOI":"10.18502\/ijrm.v20i11.12365","volume":"20","author":"Lohrasbi P.","year":"2022","unstructured":"Lohrasbi P.; Karbalay-Doust S.; Bagher Tabei S.M.; Azarpira N.; Alaee S.; Rafiee B.; Bahmanpour S.; The effects of melatonin and metformin on histological characteristics of the ovary and uterus in letrozole-induced polycystic ovarian syndrome mice: A stereological study. Int J Reprod Biomed  2022,20(11),973-988","journal-title":"Int J Reprod Biomed"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"21237","DOI":"10.1016\/j.heliyon.2023.e21237","volume":"9","author":"Basheer M.","year":"2023","unstructured":"Basheer M.; Bhat A.H.; Ahmad Hajam Y.; Batiha G.E.S.; Ataya F.S.; Fouad D.; Rai S.; Melatonin as a promising therapeutic intervention for restoring ovarian function in letrozole-induced polycystic ovary syndrome rats. Heliyon  2023,9(11),21237","journal-title":"Heliyon"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtcme.2022.08.003","volume":"12","author":"Prajapati D.P.","year":"2022","unstructured":"Prajapati D.P.; Patel M.; Dharamsi A.; Beneficial effect of polyherbal formulation in letrozole induced Polycystic ovarian syndrome (PCOS). J Tradit Complement Med  2022,12(6),575-583","journal-title":"J Tradit Complement Med"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"119020","DOI":"10.1016\/j.jep.2024.119020","volume":"338","author":"Yang W.","year":"2025","unstructured":"Yang W.; Qiu J.; Zi J.; Li Y.; Li J.; Guo M.; Zhou Y.; Yang X.; Lai Y.; Effect of Rhei Radix Et Rhizome on treatment of polycystic ovary syndrome by regulating PI3K\/AKT pathway and targeting EGFR\/ALB in rats. J Ethnopharmacol  2025,338(Pt 1),119020","journal-title":"J Ethnopharmacol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s43032-025-01813-x","volume":"32","author":"Kalimuthu V.","year":"2025","unstructured":"Kalimuthu V.; Chandran Manimegalai S.; Venkatesan R.; Krishnamoorthy S.P.; Dey N.; Ramesh T.; Balamuthu K.; Exploring the therapeutic potential of terminalia chebula retz. in alleviating the complications of letrozole-induced pcos in rat model. Reprod Sci  2025,32(3),836-853","journal-title":"Reprod Sci"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-024-01563-5","volume":"18","author":"Yang W.","year":"2025","unstructured":"Yang W.; Ma Y.; Wu Y.; Lei X.; Zhang J.; Li M.; Study on the effects of Mogroside V in inhibiting NLRP3-mediated granulosa cell pyroptosis and insulin resistance to improve PCOS. J Ovarian Res  2025,18(1),10","journal-title":"J Ovarian Res"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"116093","DOI":"10.1016\/j.biopha.2023.116093","volume":"170","author":"Zhu H.","year":"2024","unstructured":"Zhu H.; Wu Y.; Zhuang Z.; Xu J.; Chen F.; Wang Q.; Tang Q.; Ampelopsis japonica aqueous extract improves ovulatory dysfunction in PCOS by modulating lipid metabolism. Biomed Pharmacother  2024,170,116093","journal-title":"Biomed Pharmacother"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s43032-025-01820-y","volume":"32","author":"Moustafa M.A.","year":"2022","unstructured":"Moustafa M.A.; Mohamed A.S.; Dakrory A.I.; Abdelaziz M.H.; Lepidium sativum extract alleviates reproductive and developmental toxicity in polycystic ovary syndrome induced by letrozole and high-fat diet in rats. Reprod Sci  2022,32(4),1338-1361","journal-title":"Reprod Sci"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"101953","DOI":"10.1016\/j.jsps.2024.101953","volume":"32","author":"V Gadhave P.","year":"2024","unstructured":"V Gadhave P.; V Sutar G.; Sajane S.J.; Redasani V.K.; Das K.; Prasad P D.; Alobid S.; Ibrahim Almoteer A.; Imam Rabbani S.; Yasmin F.; Gilkaramenthi R.; Abdulrazaq AlAnazi M.; Jameel Alshamrani H.; Asdaq S.M.B.; Protective effects of vanillic acid on letrozole-induced polycystic ovarian syndrome: A comprehensive study in female wistar rats. Saudi Pharm J  2024,32(2),101953","journal-title":"Saudi Pharm J"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"109528","DOI":"10.1016\/j.steroids.2024.109528","volume":"213","author":"Saad M.A.","year":"2025","unstructured":"Saad M.A.; Rastanawi A.A.; El-Sahar A.E.; A Z El-Bahy A.; Ascorbic acid Mitigates behavioural disturbances associated with letrozole-induced PCOS via switching-off JAK2\/STAT5 and JAK2\/ERK1\/2 pathways in rat hippocampus. Steroids  2025,213,109528","journal-title":"Steroids"},{"key":"ref=179","first-page":"72252","volume":"16","author":"Yahia Z.","year":"2024","unstructured":"Yahia Z.; Yahia A.; Abdelaziz T.; N-acetylcysteine clinical applications. Cureus  2024,16(10),72252","journal-title":"Cureus"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s13048-024-01528-8","volume":"17","author":"Fang Y.Q.","year":"2024","unstructured":"Fang Y.Q.; Ding H.; Li T.; Zhao X.J.; Luo D.; Liu Y.; Li Y.; N-acetylcysteine supplementation improves endocrine-metabolism profiles and ovulation induction efficacy in polycystic ovary syndrome. J Ovarian Res  2024,17(1),205","journal-title":"J Ovarian Res"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s12602-024-10223-5","volume":"16","author":"Salehi S.","year":"2024","unstructured":"Salehi S.; Allahverdy J.; Pourjafar H.; Sarabandi K.; Jafari S.M.; Gut microbiota and polycystic ovary syndrome (PCOS): Understanding the pathogenesis and the role of probiotics as a therapeutic strategy. Probiotics Antimicrob Proteins  2024,16(5),1553-1565","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"106989","DOI":"10.1016\/j.prostaglandins.2025.106989","volume":"178","author":"Olaniyi K.S.","year":"2025","unstructured":"Olaniyi K.S.; Okara D.O.; Areloegbe S.E.; Suppression of adipose TGF-\u03b21 by probiotics alleviates metabolic disturbance in experimentally induced PCOS. Prostaglandins Other Lipid Mediat  2025,178,106989","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11011-025-01573-2","volume":"40","author":"Areloegbe S.E.","year":"2025","unstructured":"Areloegbe S.E.; Obong N.N.; Badejogbin O.C.; Oniyide A.A.; Ajadi I.O.; Atuma C.L.; Ajadi M.B.; Adelekan O.E.; Olaniyi K.S.; Probiotics ameliorates hypothalamic amenorrhea in a rat model of PCOS. Metab Brain Dis  2025,40(3),145","journal-title":"Metab Brain Dis"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12902-024-01688-0","volume":"24","author":"Sarvestani M.","year":"2024","unstructured":"Sarvestani M.; Rajabzadeh A.; Mazoochi T.; Samimi M.; Navari M.; Moradi F.; Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome. BMC Endocr Disord  2024,24(1),154","journal-title":"BMC Endocr Disord"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/nu17020310","volume":"17","author":"Gautam R.","year":"2025","unstructured":"Gautam R.; Maan P.; Jyoti A.; Kumar A.; Malhotra N.; Arora T.; The role of lifestyle interventions in pcos management: A systematic review. Nutrients  2025,17(2),310","journal-title":"Nutrients"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1186\/s12964-024-01939-6","volume":"22","author":"Zhao B.","year":"2024","unstructured":"Zhao B.; Wu H.; Yao Q.; Bai W.; Kang J.; A ketogenic diet alleviates the apoptosis of granulosa cells by inhibiting the activation of cGAS-STING signaling pathway in PCOS mice. Cell Commun Signal  2024,22(1),568","journal-title":"Cell Commun Signal"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"25557","DOI":"10.1038\/s41598-025-09264-9","volume":"15","author":"Soltaninejad F.","year":"2025","unstructured":"Soltaninejad F.; Shafiei G.; Rafie F.; Nematollahi-Mahani S.N.; Pourjafari F.; Haghpanah T.; Afarinesh M.R.; Ovarian epigenetics modifications following lifestyle interventions by exercise and alternate-day feeding in letrozole-induced PCOS rats. Sci Rep  2025,15(1),25557","journal-title":"Sci Rep"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010433981251031050335","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/250303\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010433981251031050335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:07:24Z","timestamp":1790914044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/250303\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":187,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010433981251031050335","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}